SONM
Dna X, Inc.
$4.16-0.19 (-4.37%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
DNA X, Inc. (SONM) is a publicly traded company with 2 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
4 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-02-09 | Crolius Clayton | CFO | Award | 35,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-10 | 2026-02-09 | Mulica Michael C | CEO | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-30 | 2025-06-30 | Lytton Laurence W | 10% Owner | Sale | 400,514 | $1.39 | -$556,714 | N/A | N/A |
| 2025-06-30 | 2025-06-26 | Lytton Laurence W | 10% Owner | Sale | 466,402 | $1.50 | -$699,603 | N/A | N/A |